Skip to content

Illicit use of ketamine in Scotland.

Phil Dalgarno, David Shewan

Journal of Psychoactive Drugs 1996 DOI: 10.1080/02791072.1996.10524391 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Qualitative study Peer reviewed
Sample size 20
Population Illicit users of ketamine in Scotland
Topics Esketamine Ketamine
Key findings Ketamine was typically obtained through diversion from legitimate sources, used in a standard dose of 1/8 g intranasally, and produced an intense dissociative experience lasting about one hour, with potential for psychological dependence among extensive users.

Abstract

Semistructured interviews were carried out with 20 illicit users of ketamine in Scotland. Participants had used a wide range of illegal drugs. Scottish drug agencies reported limited contact with ketamine users; however, subjects were knowledgeable regarding the licit purpose of ketamine, its effects, and its legal status. Ketamine was usually obtained through diversion from legitimate sources. Three participants reported extensive use, indicating the potential for psychological dependence. A standard dose of ketamine was typically 1/8 g, usually taken intranasally. Participants reported the ketamine experience as being extremely intense and dissociative, usually lasting for approximately one hour. All participants reported using ketamine in a carefully preplanned setting, emphasizing comfort, security, and familiarity. Participants identified potential problems arising from using ketamine in a public place, or in unfamiliar surroundings, and also suggested that novice users may encounter problems through lack of knowledge concerning the intense nature of the experience. Accurate information concerning the effects and nature of ketamine as well as the importance of set and setting should be made available. However, publicizing the drug should be avoided as widespread interest could cause greater problems than currently exist.

Comparable studies

Other qualitative studies on ketamine, most cited first.

Study Year Design Participants
Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency? 2017 Qualitative review
Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study. Patients with treatment-resistant depression participating in off-label oral esketamine... 2022 Qualitative study n = 17
A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression Healthcare providers 2022 Quality improvement evaluation with mixed methods n = 94
Predictors of Psychedelic Experience: A Thematic Analysis First-person reports of psychedelic use from the Erowid database (six reports each for... 2022 Thematic analysis n = 22
Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychopathological Psychotic Experiences and Psychotic Disorders Experts in psychiatry, clinical psychology, medicine, and psychedelic effects 2024 Qualitative study n = 12

Citations in the library

Explore topics